Domenico Pascucci

Dr. Domenico Pascucci

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
MNMario Cesare Nurchis
Mario Cesare Nurchis
DPDomenico Pascucci
Domenico Pascucci
MSMartina Sapienza
Martina Sapienza
LVLeonardo Villani
Leonardo Villani
FDFloriana D'Ambrosio
Floriana D'Ambrosio
Gianfranco DamianiGianfranco Damiani
Gianfranco Damiani
The WHO declared the novel coronavirus disease a pandemic, with severe consequences for health and global economic activity and Italy is one of the hardest hit countries. This study aims to assess the socio-economic burden of COVID-19 pandemic in Italy through the estimation of Disability-Adjusted Life Years (DALYs) and productivity loss. The observational study was based on data from official governmental sources collected since the inception of epidemic until 28 April 2020. DALYs for a disease combines the years of life lost due to premature mortality in the population and the years lost due to disability of the disease. In addition to DALYs, temporary productivity loss due to absenteeism from work and permanent productivity loss due to premature mortality were estimated using the Human Capital Approach. The total DALYs amount to 2.01 per 1000 persons. The total permanent productivity loss was around EUR 300 million while the temporary productivity loss was around EUR 100 million. This evaluation does not consider other economic aspects related to lockdown, quarantine of contacts, healthcare direct costs etc. The burden of disease methodology is functional metric for steering choices of health policy and allowing the government to be accountable for the utilization of resources.

1 February 2021 in Health Policy
Verified
Journal Article
Closed access
DPDomenico Pascucci
Domenico Pascucci
MSMichele Sassano
Michele Sassano
MNMario Cesare Nurchis
Mario Cesare Nurchis
MCMichela Cicconi
Michela Cicconi
AAAnna Acampora
Anna Acampora
GDGianfranco Damiani
Gianfranco Damiani

Verified
Journal Article
Open access
PDF file
MNMario Cesare Nurchis
Mario Cesare Nurchis
GSGiorgio Sessa
Giorgio Sessa
DPDomenico Pascucci
Domenico Pascucci
MSMichele Sassano
Michele Sassano
LLLinda Lombi
Linda Lombi
Gianfranco DamianiGianfranco Damiani
Gianfranco Damiani
The global spread of diabetes poses serious threats to public health requiring a patient-centered approach based both on interprofessional collaboration (IPC) given by the cooperation of several different health professionals, and patients’ perspective through the assessment of Patient-Reported Outcomes (PROs). The aim of the present study is to evaluate the impact of interprofessional collaboration interventions, for the management of type 2 diabetes in primary care settings, through PROs. A systematic review and meta-analysis was conducted querying the PubMed, Scopus and Embase databases. Out of the 1961 papers initially retrieved, 19 met the inclusion criteria. Interprofessional collaboration is significantly associated with an increase in both patient’s satisfaction (SMD 0.32 95% CI 0.05–0.59) and in the mental well-being component of the HRQoL (SMD 0.18; 95% CI 0.06–0.30), and there was also promising evidence supporting the association between an interprofessional approach and an increase in self-care and in generic and specific quality-of-life. No statistical differences were found, supporting the positive impact on IPC interventions on the physical component of the HRQoL, depression, emotional distress, and self-efficacy. In conclusion, the effect of IPC impacts positively on the few areas assessed by PROMs. Policymakers should promote the widespread adoption of a collaborative approach as well as to endorse an active engagement of patients across the whole process of care.

18 March 2021 in Vaccines
Verified
Journal Article
Open access
PDF file
MPMarcello Di Pumpo
Marcello Di Pumpo
GVGiuseppe Vetrugno
Giuseppe Vetrugno
DPDomenico Pascucci
Domenico Pascucci
ECElettra Carini
Elettra Carini
VBViria Beccia
Viria Beccia
PLPatrizia Laurenti
Patrizia Laurenti
Seasonal flu vaccination is one of the most important strategies for preventing influenza. The attitude towards flu vaccination in light of the COVID-19 pandemic has so far been studied in the literature mostly with the help of surveys and questionnaires. Whether a person chooses to be vaccinated or not during the COVID-19 pandemic, however, speaks louder than any declaration of intention. In our teaching hospital, we registered a statistically significant increase in flu vaccination coverage across all professional categories between the 2019/2020 and the 2020/2021 campaign (24.19% vs. 54.56%, p < 0.0001). A linear regression model, based on data from four previous campaigns, predicted for the 2020/2021 campaign a total flu vaccination coverage of 30.35%. A coverage of 54.46% was, instead, observed, with a statistically significant difference from the predicted value (p < 0.0001). The COVID-19 pandemic can, therefore, be considered as an incentive that significantly and dramatically increased adherence to flu vaccination among our healthcare workers.

28 September 2022 in Vaccines
Verified
Journal Article
Open access
PDF file
CCChiara Cadeddu
Chiara Cadeddu
ARAldo Rosano
Aldo Rosano
LVLeonardo Villani
Leonardo Villani
GCGiovanni Battista Coiante
Giovanni Battista Coiante
IMIlaria Minicucci
Ilaria Minicucci
Chiara de WaureChiara de Waure
Chiara de Waure
The initial progress of the COVID-19 vaccination campaign worldwide depended on several aspects, including programmatic/practical issues. This paper focused on the planning and organization of COVID-19 vaccination campaigns in eight European countries (Sweden, Denmark, Romania, Hungary, Italy, Spain, Germany, and France), from the launch to August 2021. Information on the planning of the vaccination campaign (release and update of a national immunization plan, types of vaccines being used and their limitations/suspensions) and its organization (vaccination target groups, possibility of citizens’ choice, vaccination workforce and settings, vaccines procurement) were obtained through desk research of international and national reports, plans, and websites. Eventually, data on vaccination coverage were drawn from Our world in data and analyzed through join point regression. The eight countries showed differences in groups prioritization, limitations/suspensions of use of specific vaccines, citizens’ possibility to choose vaccines, and vaccination workforce involved. These issues could have contributed to the different progress towards high levels of vaccination coverage. In respect to vaccination coverage, Romania reached much lower levels than other countries. Further comparative research is needed in order to identify best practices in vaccination campaign that could be useful for the next phases of the COVID-19 pandemic, and be better prepared for future potential pandemic.

19 June 2022 in Vaccines
Verified
Journal Article
Open access
PDF file
DPDomenico Pascucci
Domenico Pascucci
MNMario Cesare Nurchis
Mario Cesare Nurchis
ALAlberto Lontano
Alberto Lontano
EMEleonora Marziali
Eleonora Marziali
GVGiuseppe Vetrugno
Giuseppe Vetrugno
PLPatrizia Laurenti
Patrizia Laurenti
Influenza represents a threat to global health and health care workers (HCWs) have an increased risk of contracting the influenza virus in the workplace. The COVID-19 pandemic has brought back the importance of influenza vaccination, as the influenza virus can circulate together with SARS-CoV-2. The aim of this report is to describe the actual flu vaccination coverage among healthcare workers of a research hospital and the trend changes, with respect to the past flu vaccination campaigns, in light of the present pandemic and COVID-19 vaccination. A Pearson’s χ2 test was used to test the correlation of flu vaccination coverage, across all professional categories, between the last two years. A linear regression model was adopted to predict the total vaccination coverage of this year. A statistically significant decrease (p < 0.01) was observed in vaccination coverage among all the professional categories with a 50% reduction in vaccination trends between the last two years. Analyzing the data from the previous six flu vaccination campaigns, the expected value, according to the linear regression model, was estimated to be 38.5% while the observed value was 24%. The decrease in vaccination coverage may be due to the fear of the pandemic situation and especially to the uncertainty related to the consequences of a concurrent administration which may overload the immune system or may be more reactogenic. The COVID-19 pandemic represents an opportunity to promote and support large-scale influenza vaccination among HCWs through structured programs, adequate funding, and tailored communication strategies.